Burden of Disease and Economic Impact of Dengue and Severe Dengue in Colombia, 2011

Value in Health Regional Issues

Volumn 1, Issue 2, 2012, Pages 123-128

  Castañeda Orjuela, Carlos ^a   Díaz, Hernando ^a   Alvis Guzman, Nelson ^b   Olarte, Andres ^a   Rodriguez, Heidy ^b   Camargo, Guido ^a   De la Hoz Restrepo, Fernando ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b UNIVERSIDAD DE CARTAGENA   (Colombia)

Author keywords

Colombia; Cost of illness; Costs and cost analysis; Dengue; Models

Indexed keywords

AMBULATORY CARE; ARTICLE; COLOMBIA; DENGUE; DISEASE CONTROL; DISEASE MODEL; DISEASE SEVERITY; DISEASE SURVEILLANCE; ECONOMIC ASPECT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INCIDENCE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PUBLIC HEALTH; VECTOR CONTROL;

EID: 84870885794     PISSN: 22121099     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vhri.2012.09.014     Document Type: Article

References (29)

1. Pan American Health Organization. Dengue and Hemorrhagic Dengue 1990-2002. Washington, DC: Pan American Health Organization, 2003.
2. Scientific Working Group on Dengue. Report of the Scientific Working Group on Dengue, 1-5 October 2006. Geneva: World Health Organization, 2007.
3. Guzman M.G., Kouri G. Dengue: an update. Lancet Infect Dis 2002, 2:33-42.
4. Wilder-Smith A., Gubler D.J. Geographic expansion of dengue: the impact of international travel. Med Clin North Am 2008, 92:1377-1390.
5. Ooi E.-E., Gubler D.J. Global spread of epidemic dengue: the influence of environmental change. Future Virol 2009, 4:571-580.
6. Vélez S., Núñez C.P., Ruíz D. Hacia la construcción de un modelo de simulación de la transmisión del dengue en Colombia. Revista EIA 2006, 5:23-43.
7. Gubler D.J., Clark G.G. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis 1995, 1:55-57.
8. Halstead S.B. Pathogenesis of dengue: challenges to molecular biology. Science 1988, 239:476-481.
9. Gubler D.J. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002, 10:100-103.
10. Standish K., Kuan G., Aviles W., et al. High dengue case capture rate in four years of a cohort study in Nicaragua compared to national surveillance data. PLoS Negl Trop Dis 2010, 4:e633.
11. Dechant E.J., Rigau-Perez J.G. Hospitalizations for suspected dengue in Puerto Rico, 1991-1995: estimation by capture-recapture methods. The Puerto Rico Association of Epidemiologists. Am J Trop Med Hyg 1999, 61:574-578.
12. Keating J. An investigation into the cyclical incidence of dengue fever. Soc Sci Med 2001, 53:1587-1597.
13. Fuller D.O., Troyo A., Beier J.C. El Nino Southern Oscillation and vegetation dynamics as predictors of dengue fever cases in Costa Rica. Environ Res Lett 2009, 4:140111-140118.
14. Shepard D.S., Coudeville L., Halasa Y.A., et al. Economic impact of dengue illness in the Americas. Am J Trop Med Hyg 2011, 84:200-207.
15. Guy B., Nougarede N., Begue S., et al. Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects. Vaccine 2008, 26:5712-5721.
16. Sun W., Cunningham D., Wasserman S.S., et al. Phase 2 clinical trial of three formulations of tetravalent live-attenuated dengue vaccine in flavivirus-naive adults. Hum Vaccin 2009, 5:33-40.
17. Martín J.S., Prado M. Percepción del riesgo y estrategias de comunicación social sobre el dengue en las Américas. Revista Panamericana de Salud Pública 2004, 15:135-139.
18. Halasa Y.A., Shepard D.S., Zeng W. Economic cost of dengue in Puerto Rico. Am J Trop Med Hyg 2012, 86:745-752.
19. Armien B., Suaya J.A., Quiroz E., et al. Clinical characteristics and national economic cost of the 2005 dengue epidemic in Panama. Am J Trop Med Hyg 2008, 79:364-371.
20. Harving M.L., Ronsholt F.F. The economic impact of dengue hemorrhagic fever on family level in Southern Vietnam. Danish Med Bull 2007, 54:170-172.
21. Suaya J.A., Shepard D.S., Siqueira J.B., et al. Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. Am J Trop Med Hyg 2009, 80:846-855.
22. Anez G., Balza R., Valero N., Larreal Y. Economic impact of dengue and dengue hemorrhagic fever in the state of Zulia, Venezuela, 1997-2003. Rev Panam Salud Publica 2006, 19:314-320.
23. Natera I., Garrido E., Martín A. Consecuencias del dengue hemorrágico en niños. Bol Venez Infectol 2009, 20:17-23.
24. Valdes L.G., Mizhrahi J.V., Guzman M.G. Economic impact of dengue 2 epidemic in Santiago de Cuba, 1997. Rev Cubana Med Trop 2002, 54:220-227.
25. Harris E., Videa E., Perez L., et al. Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg 2000, 63:5-11.
26. Garg P., Nagpal J., Khairnar P., Seneviratne S. Economic burden of dengue infections in India. Trans R Soc Trop Med Hyg 2008, 102:570-577.
27. Shepard D, editor. Aggregate economic cost of dengue in Puerto Rico. In: Proceedings of the 58th Annual Meeting of the American Society of Tropical Medicine and Hygiene. Washington, DC, November 18-22, 2009.
28. Kongsin S., Jiamton S., Suaya J.A., et al. Cost of Dengue in Thailand 2010, Mahidol University School of Public Health, Bangkok, Thailand.
29. Huy R., Wichmann O., Beatty M., et al. Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study. BMC Public Health 2009, 9:155.